The NYT investigation highlights rapid industry growth and overbilling in autism therapy clinics, but misses deeper patterns linking financial structures to diluted treatment fidelity. Peer-reviewed evidence, such as a 2019 RCT in the Journal of the American Academy of Child & Adolescent Psychiatry (n=152, no industry conflicts) on early intensive behavioral intervention, shows modest gains in adaptive functioning only when sessions exceed 20 hours weekly with high fidelity—yet observational Medicaid claims data from 2022 CMS reports reveal average billed hours often prioritize volume over intensity. A separate 2021 observational cohort study in Autism (n=487, funded partly by therapy providers) found associations between clinic ownership models and 30% higher service utilization without corresponding outcome improvements, suggesting selection bias inflates apparent needs. Original coverage overlooks how these incentives parallel prior fraud patterns in early intervention programs, where small sample sizes in efficacy trials limit generalizability to real-world Medicaid populations facing comorbidities.